Commissioning, Qualification, and Validation in Life Sciences: What's the Difference

If you've spent any time in a pharmaceutical plant, a biotechnology facility, or a contract manufacturing organization, you have likely heard the terms Commissioning, Qualification, and Validation used frequently. In some cases, they are used interchangeably. In others, they become the subject of cross-functional discussion between Engineering, Validation, and Quality Assurance (QA). The confusion is understandable.

Commissioning, Qualification, and Validation often occur in sequence, and they can overlap in practice. However, they serve different purposes and carry different regulatory and quality expectations.

Let's break it down with a clear, practical explanation:

Think of it this way:

• Commissioning asks: Does this equipment work the way the vendor said it would?

• Qualification asks: Does this equipment work the way we need it to work, in our environment, for our intended use?

• Validation asks: Does this entire process, consistently and reproducibly, produce the result we need, every single time?
  

Each layer builds on the one before it. If one is skipped or poorly executed, the entire control strategy can become vulnerable.

Commissioning: The Engineering Handshake

Commissioning is typically an engineering-led activity. When a new piece of equipment arrives at your facility, such as a bioreactor, an HVAC system, or a purified water loop, Commissioning is the process of verifying that it was built and installed correctly and functions according to the vendor's design specifications.

While Commissioning is not typically a direct regulatory requirement, it is an important engineering and business practice that supports a smoother transition into Qualification.

Commissioning typically includes:

• Factory Acceptance Testing (FAT), performed at the vendor's site before the equipment ships

• Site Acceptance Testing (SAT), performed after installation at your facility

• Verification of utilities, connections, alarm systems, and basic operational functionality

• Confirmation that the delivered equipment matches what was ordered
  

A well-executed Commissioning program can save significant time and cost during Qualification by reducing unnecessary duplication of testing. When Commissioning activities are planned, documented, and executed with sufficient rigor, the resulting data may be leveraged to support Qualification activities, provided there is appropriate quality oversight, traceability to requirements, a risk-based rationale, and documented justification. 

Who owns Commissioning? Engineering. With input from QA to ensure documentation meets expectations for later review.

Qualification: The GxP Bridge

This is where formal GxP documentation and regulatory expectations become more prominent. Qualification is the formal, documented process of demonstrating that equipment, utilities, facilities, and systems are appropriately designed, installed, operated, and, where applicable, perform as intended for their GxP use.

It is not enough that your filling line runs smoothly. You need documented, reviewed, and approved evidence that it runs within the parameters required to produce a safe and effective product.

Qualification is typically structured in phases:

Design Qualification (DQ)

Does the system's design meet our user requirements? DQ confirms that the proposed design is suitable for the intended use and aligned with approved user requirements before procurement, fabrication, or implementation.

Installation Qualification (IQ)

IQ documents the installed configuration, including relevant components, utilities, instruments, software or firmware versions, calibration status, drawings, and other critical installation attributes that support GxP use.

Operational Qualification (OQ)

Does the equipment operate correctly throughout its operating range? OQ challenges the system across its approved operating range. This may include normal operating conditions, boundary conditions, alarms, interlocks, failure scenarios, and other critical functions defined by risk and intended use.

Performance Qualification (PQ)

PQ demonstrates whether the equipment performs consistently under actual conditions of use. It serves as the bridge between equipment Qualification and process Validation by answering a practical question: "In our hands, with our materials, under our conditions, does this reliably perform?”

Regulatory grounding: Qualification expectations appear across multiple frameworks including regulatory guidance from the U.S. Food & Drug Administration (FDA), European Union (EU) Good Manufacturing Practice (GMP) Annex 15, and Health Canada's GUI-0036. The specific requirements and terminology can vary by framework and product type. Always verify against the applicable regulatory authority's current published guidance.

Who owns Qualification? Validation/QA teams, with technical input from engineering and subject matter experts.

Validation: The Process-Level Proof

Once equipment and systems have been qualified, Validation expands the focus from individual assets to the process as a whole. 

While Commissioning and Qualification focus on equipment and systems, Validation zooms out to look at the bigger picture: your process. Can it reliably, repeatedly, and consistently produce outputs that meet predefined quality attributes, specifications, and acceptance criteria? That is what Validation sets out to prove.

You can have a perfectly qualified autoclave, but if your sterilization process, loading pattern, cycle parameters, and container configuration haven't been validated, you do not have validated sterility assurance.

Types of Validation You'll Encounter:

Process Validation

(e.g., manufacturing processes, cleaning processes, sterilization)

Typically follows a three-stage lifecycle model:

1. Process Design: understanding the process through development and scale-up

2. Process Qualification: confirming the process design at commercial scale

3. Continued Process Verification: ongoing assurance that the process remains in a state of control

   
   

Analytical Method Validation

Demonstrates that a test method reliably measures what it is supposed to measure: accuracy, precision, specificity, linearity, range, robustness. ICH Q2(R2) provides the foundational framework.

Computer System Validation (CSV) / Computer Software Assurance (CSA)

Computer System Validation (CSV) establishes that the system performs as intended, protects data integrity, and supports audit trail and access control requirements aligned with 21 CFR Part 11 and EU GMP Annex 11. FDA’s CSA guidance reflects a risk-based approach to software assurance for production and quality system software. It emphasizes intended use, patient safety, product quality, and data integrity, while allowing greater flexibility in testing methods and documentation. It does not replace applicable regulatory requirements such as 21 CFR Part 11 or predicate rules. Many organizations now apply CSA principles within their existing CSV programs.

Cleaning Validation

Documents that cleaning procedures consistently reduce product residues, cleaning agents, and microbial contamination to acceptable levels between product campaigns or batches.

Who owns Validation? Validation/QA teams, with cross-functional input from manufacturing, analytical, regulatory affairs, and engineering.

How They Fit Together: A Practical Sequence

A practical example helps show how the three activities fit together: you're installing a new sterile filling line.

Commissioning: Your engineering team works with the vendor to verify the line is mechanically complete, all utilities are connected, and it runs at the speeds advertised. FAT is done at the vendor's facility. SAT is done once it's on your floor. 

Qualification (IQ/OQ/PQ): Your Validation team takes over. IQ documents the installation. OQ challenges the operational envelope: speed ranges, alarm functionality, reject mechanisms, environmental controls. PQ demonstrates the line performs consistently under actual production conditions. 

Validation: Now that the equipment is qualified, you validate the filling process itself. You define your critical process parameters and critical quality attributes. You run Validation batches. You generate evidence that your process will consistently produce filled product that meets specifications.

Until the required Commissioning, Qualification, and Validation activities are completed, documented, reviewed, and approved in accordance with the defined Validation strategy, the filling line should not be released for GMP production. That is not bureaucracy; it is a fundamental element of patient safety. 

Quick Reference Summary

	Commissioning	Qualification	Validation
Focus	Verifying that equipment is built and installed according to design and purchase specifications	Demonstrating that equipment, utilities, and systems are fit for their intended GxP use	Demonstrating that a process consistently produces output that meets predefined quality attributes, specifications, and acceptance criteria
Governed by	Technical and manufacturer specifications	Applicable GxP regulations and guidance (e.g., EU GMP Annex 15, Health Canada GUI-0036)	Applicable GxP regulations and guidance (e.g., FDA Process Validation Guidance, ICH Q2(R2))
Regulatory requirement?	Not directly	Yes	Yes
Primary owner	Engineering, with vendor support	Validation / QA teams, with engineering input	Validation / QA teams, with cross-functional input
Key output	FAT and SAT reports	IQ, OQ, PQ protocols and reports	Validation protocols, reports, and summary reports
Risk if skipped	Operational gaps, equipment failures, and costly rework during Qualification	Regulatory non-compliance, failed audits, and batch rejection	Product quality failures, patient safety risk, and regulatory action

The Common Mistakes We See in the Field

In our experience across client programs, a few patterns keep coming up:

1. Treating Commissioning data as Qualification data without a rationale.

Commissioning data can support Qualification, but only when there is documented, justified rationale for its use. Simply pasting FAT data into an IQ protocol without critical review is a gap waiting to become a finding.

2. Writing OQ tests that only test the "happy path."

Qualification exists to give you confidence the system behaves correctly at its operating limits. If all your OQ tests run at nominal conditions, you haven't actually qualified the system, you've just documented that it works when everything is fine.

3. Starting Validation before prerequisite Qualification activities are complete or appropriately justified.

In most cases, Qualification should be completed, reviewed, and approved before Validation begins. If any prerequisite activities remain open, they should be assessed, justified, and controlled in accordance with the approved Validation strategy.

4. Forgetting requalification and revalidation triggers.

Qualification and Validation are not one-time events. Changes to equipment, facilities, processes, or software may necessitate revisiting prior Qualification and Validation status. But requalification and revalidation aren’t only change-triggered, many organizations also establish scheduled periodic reviews to confirm continued validated state independent of any specific change. A robust change control program, combined with a defined periodic review schedule, helps maintain a continued state of control. 

To Conclude

Commissioning, Qualification, and Validation are not bureaucratic hurdles. They are the foundation that gives your organization confidence, and the evidence to prove to regulators that your facility, your equipment, and your processes are capable of doing exactly what you say they can do.

Done right, they protect patients, your data, and your business.

When performed poorly, or rushed to meet a launch date, these activities can contribute to audit findings, regulatory observations, warning letters, remediation programs, and significant business disruption.

Take the time to understand the distinctions. Build them into your project plans from day one, and if you're not sure where your current program stands, an independent gap assessment is always a reasonable place to start.

 Regulatory references:

• European Commission. (2011). EU guidelines for good manufacturing practice for medicinal products for human and veterinary use -- Annex 11: Computerised systems. European Medicines Agency.

• European Commission. (2015). EU guidelines for good manufacturing practice for medicinal products for human and veterinary use -- Annex 15: Qualification and validation. European Medicines Agency.

• Health Canada. (2023). Validation guidelines for pharmaceutical dosage forms (GUI-0036). Government of Canada.

• International Council for Harmonisation. (2022). ICH Q2(R2): Validation of analytical procedures. ICH.

• International Society for Pharmaceutical Engineering. (2022). GAMP 5: A risk-based approach to compliant GxP computerized systems (2nd ed.). ISPE.

• U.S. Food and Drug Administration. (2011). Process validation: General principles and practices (Guidance for industry). U.S. Department of Health and Human Services.

• U.S. Food and Drug Administration. (n.d.). 21 CFR Part 11: Electronic records; electronic signatures. Electronic Code of Federal Regulations.